Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine ind...
Q1 2026
May 13, 2026
FY 2025
Mar 17, 2026
Q4 2025
Q3 2025
Nov 20, 2025
Q2 2025
Aug 12, 2025
